HELOMICS CORPORATION Trademark Portfolio
HELOMICS CORPORATION owns 0 live USPTO trademarks across 5 Nice classes. Earliest filing: 2015-04-23; most recent: 2022-05-05.
Portfolio Overview
| Total Marks | 53 |
|---|---|
| Live Marks | 0 |
| Registered | 0 |
| Pending | 0 |
| Earliest Filing | 2015-04-23 |
| Latest Filing | 2022-05-05 |
Top Classes
Class 042 (Software & IT), Class 044 (Medical Services), Class 005 (Pharmaceuticals), Class 041 (Education & Entertainment), Class 035 (Advertising & Business)
Recently Filed Applications
- Trademark 97397035 — filed 2022-05-05 (Abandoned)
- Trademark 97397061 — filed 2022-05-05 (Abandoned)
- Trademark 97393397 — filed 2022-05-03 (Abandoned)
- PRECISION THERAPEUTICS — filed 2016-08-01 (Abandoned)
- CELLFX — filed 2016-01-25 (Abandoned)
Top Marks
- Trademark 86620688 — Cancelled
- Trademark 86620648 — Cancelled
- Trademark 86620740 — Cancelled
- Trademark 97397035 — Abandoned
- Trademark 97397061 — Abandoned
- Trademark 97393397 — Abandoned
- PRECISION THERAPEUTICS — Abandoned
- CELLFX — Abandoned
- CELLFX — Abandoned
- CELLFX — Abandoned
- CELLFX — Abandoned
- CELLFX — Abandoned
- PRECISION CELLULAR ANALYTICAL PLATFORM — Abandoned
- PCAP — Abandoned
- PCAP — Abandoned
- PRECISION CELLULAR ANALYTICAL PLATFORM — Abandoned
- Trademark 86620698 — Abandoned
- Trademark 86620679 — Abandoned
- GENEEX — Abandoned
- GENEEX — Abandoned
- PARPTX — Abandoned
- PROTEINEX — Abandoned
- GENEEX — Abandoned
- CHEMOTX — Abandoned
- PARPTX — Abandoned
- PARPTX — Abandoned
- ANGIOTX — Abandoned
- GENESQ — Abandoned
- GENEEX — Abandoned
- CHEMOTX — Abandoned
- PROTEINEX — Abandoned
- CHEMOTX — Abandoned
- GENESQ — Abandoned
- PROTEINEX — Abandoned
- CHEMOTX — Abandoned
- CHEMOTX — Abandoned
- PROTEINEX — Abandoned
- GENESQ — Abandoned
- PARPTX — Abandoned
- ANGIOTX — Abandoned
- ANGIOTX — Abandoned
- GENEEX — Abandoned
- PARPTX — Abandoned
- GENESQ — Abandoned
- PROTEINEX — Abandoned
- ANGIOTX — Abandoned
- ANGIOTX — Abandoned
- GENESQ — Abandoned
- PROTEINSQ — Abandoned
- PROTEINSQ — Abandoned